Heterotopic heart transplantation is still indicated in selected patients mainly with
pulmonary vascular bed problems. Cardio-pulmonary bypass (CPB) has well known deleterious
effects on the pulmonary vascular bed due to leukocyte sequestration as well as on
the immune response of the patients. Also the negative effects of the cardioplegia
on the native heart is another drawback of the classical heterotopic heart transplantation
with the use of CPB. We want to present our new implantation technique for heterotopic
heart transplantation without CPB, used successfully in our institution at the Kocaeli
University on a patient with resistant pulmonary hypertension and dilated cardiomyopathy.
Heterotopic transplantation - Beating heart
